CASPER is a prospective clinical cohort follow-up study in 250 first-ever and recurrent ischemic and hemorrhagic stroke patients. Patients were recruited at the neurological in- and outpatient services at Maastricht University Medical Center (MUMC+, Maastricht, The Netherlands), and Zuyderland Medical Center (Sittard and Heerlen, The Netherlands). The stroke can be a first-ever event or a recurrent supra- or infratentorial stroke in a patient who recovered from a previous event without obvious residual symptoms. The study has serial assessments at baseline (10 to 12 weeks after stroke), followed up 6, 12, and 36 months after baseline.
Study design
Cohort - clinical
Number of participants at first data collection
250 (participants)
Age at first data collection
≥ 40 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2013
Primary Institutions
Maastricht University (Universiteit Maastricht, UM)
Links
Profile paper DOI
Funders
Adriana van Rinsum-Ponsen Foundation (Adriana van Rinsum-Ponsen Stichting)
Health Foundation Limburg (HFL)
Maastricht University
Ongoing?
No
Data types collected


Engagement
Keywords
Consortia and dataset groups